Titan Medical Inc.
TSX:TMD.TO
1.125 (CAD) • At close October 15, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) CAD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 17.632 | 0 | 20.093 | 20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 17.632 | 0 | 20.093 | 20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 0.321 | 33.007 | 37.955 | 7.937 | 51.418 | 32.858 | 12.901 | 22.578 | 38.213 | 10.679 | 5.179 | 4.662 | 12.482 | 1.574 | 0.159 | 1.442 | 0.151 |
| General & Administrative Expenses
| 8.362 | 11.48 | 12.426 | 7.488 | 7.525 | 6.572 | 5.688 | 4.529 | 3.202 | 3.304 | 3.254 | 2.963 | 3.07 | 1.972 | 0.548 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0.141 | 0.289 | 0.231 | 0.278 | 0.396 | 0.324 | 0.195 | 0.112 | 0.127 | 0.241 | 0.135 | 0.012 | 0 | 0 |
| SG&A
| 8.362 | 11.48 | 12.426 | 7.629 | 7.815 | 6.803 | 5.966 | 4.925 | 3.525 | 3.499 | 3.366 | 3.09 | 3.311 | 2.107 | 0.56 | 0.692 | 0.132 |
| Other Expenses
| 1.314 | 0 | 0.699 | 0.237 | 0.033 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 8.683 | 42.595 | 51.08 | 15.803 | 59.265 | 39.69 | 18.884 | 27.528 | 41.771 | 14.202 | 8.835 | 7.885 | 15.889 | 3.722 | 0.742 | 2.154 | 0.303 |
| Operating Income
| 4.839 | -44.487 | -30.987 | 2.946 | -61.247 | -54.177 | -18.884 | -27.528 | -41.771 | -14.202 | -8.835 | -7.885 | -15.889 | -3.722 | -0.742 | -2.154 | -0.303 |
| Operating Income Ratio
| 0.274 | 0 | -1.542 | 0.147 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| -2.059 | 1.889 | 16.185 | -27.13 | 19.34 | 18.075 | -13.676 | 4.673 | 0.269 | 0.446 | -0.175 | 0.087 | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax
| 6.977 | -42.598 | -14.802 | -24.185 | -41.907 | -22.639 | -33.587 | -23.323 | -41.413 | -13.45 | -8.775 | -7.798 | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax Ratio
| 0.396 | 0 | -0.737 | -1.209 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0.024 | 0.056 | 0.056 | 1.091 | 0.423 | -17.051 | 14.703 | -4.204 | -0.358 | -0.751 | -0.234 | -0 | -0.093 | -0.034 | -0.028 | 0.149 | 0.028 |
| Net Income
| 6.953 | -42.542 | -14.858 | -25.276 | -42.33 | -22.639 | -33.587 | -23.323 | -41.413 | -13.45 | -8.775 | -7.798 | -15.796 | -3.688 | -0.714 | -2.302 | -0.331 |
| Net Income Ratio
| 0.394 | 0 | -0.739 | -1.264 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| 0.06 | -0.38 | -0.14 | -0.38 | -1.38 | -1.36 | -4.25 | -4.77 | -11.92 | -4.29 | -3.75 | -3.65 | -8.73 | -2.57 | -0.64 | -2.94 | -0.62 |
| EPS Diluted
| 0.06 | -0.38 | -0.14 | -0.38 | -1.38 | -1.36 | -4.25 | -4.77 | -11.92 | -4.29 | -3.75 | -3.65 | -8.73 | -2.57 | -0.64 | -2.94 | -0.62 |
| EBITDA
| 10.757 | -44.033 | -29.61 | 2.646 | -61.214 | -57.736 | -5.19 | -32.176 | -42.008 | -14.624 | -8.545 | -7.752 | -15.793 | -3.681 | -0.719 | -2.134 | -0.283 |
| EBITDA Ratio
| 0.61 | 0 | -1.474 | 0.132 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |